Pairing ion-pairing chromatography with accurate mass detection enables identification, sequencing, and quantification of oligonucleotide impurities for more accurate purity analysis.
Discover how integrated expertise, flexible capacity, advanced technologies, and global reach can support pharmaceutical products throughout each stage of their lifecycle.
AAV lot release testing evolves from bulk harvest through drug product release to guarantee safety, purity, and potency. Structured testing strategies ensure compliance and consistency.
View integrated analytical development for biosimilars, supporting characterization, comparability, validation, and regulatory submissions through co-located expertise and experience.
Explore how advanced microbial platforms and integrated manufacturing enable scalable biopharma production, speeding development and ensuring consistent, high-quality output.
Recent studies offer insights on formulation, device compatibility, stability testing, and fill‑finish optimization — helping teams boost product performance and cut development risk.
Look at how optimized virus banking strengthens manufacturing by enhancing consistency, speeding characterization timelines, and aligning testing strategies with modern regulatory expectations.
New advances in chemomics, proteome mapping, and modern synthetic methods are redefining how quickly and precisely teams can move from raw data to meaningful clinical momentum.
Re-engineer your drug's path into clinical development and accelerate time to Proof-of-Concept. Real-time data guides rapid formulation iterations, minimizing drug substance use and lowering program risk.
